Forbes February 28, 2024
We have a serious problem of affordability of healthcare in the U.S., including the cost of many innovative pharmaceuticals, making access to life-saving drugs beyond the reach of some Americans. The problem of healthcare costs and what the U.S. spends is a decades long issue, largely rooted in a broken fee-for-service model, a subject which I’ve covered in other columns. A serious look at overall healthcare costs and access must also include a focus on pharmaceuticals and where drugs fit into the ecosystem.
Pharmaceutical costs account for approximately 14% of the total healthcare spend, so even if we eliminated all drug costs, the U.S. would still be paying more per capita than many other industrialized countries. If we were achieving...
Today's Sponsors
Today's Sponsor